Target type: biologicalprocess
The transfer of a phospholipid from its site of synthesis to the plasma membrane. [GOC:go_curators]
Phospholipid transfer to membranes is a crucial biological process that involves the movement of phospholipids between different membrane compartments within a cell. This dynamic process plays a vital role in maintaining membrane integrity, regulating membrane composition, and facilitating signal transduction.
**Mechanism:**
The transfer of phospholipids is primarily mediated by specialized proteins known as phospholipid transfer proteins (PLTPs). These proteins exhibit high affinity for specific phospholipid classes, such as phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylinositol (PI), and phosphatidylserine (PS).
PLTPs function by binding to a phospholipid molecule in one membrane and then diffusing through the aqueous environment to another membrane, where they release the phospholipid. This process involves a series of steps:
1. **Binding:** PLTPs bind to a phospholipid molecule in the donor membrane.
2. **Extraction:** The PLTP extracts the phospholipid from the donor membrane, forming a transient complex.
3. **Translocation:** The PLTP, carrying the phospholipid, diffuses through the cytosol to the acceptor membrane.
4. **Insertion:** The PLTP inserts the phospholipid into the acceptor membrane.
**Biological Significance:**
Phospholipid transfer to membranes is essential for a variety of cellular functions, including:
* **Membrane biogenesis:** The transfer of phospholipids is crucial for the assembly and maintenance of new membranes, such as those of the endoplasmic reticulum (ER), Golgi apparatus, and plasma membrane.
* **Membrane remodeling:** PLTPs contribute to the dynamic remodeling of membranes, allowing for adjustments in lipid composition and fluidity in response to changing cellular needs.
* **Signal transduction:** Phospholipid transfer plays a role in signal transduction pathways by regulating the distribution of signaling lipids, such as phosphatidylinositol 4,5-bisphosphate (PIP2), which is involved in various cellular processes.
* **Membrane repair:** PLTPs can facilitate the repair of damaged membranes by delivering phospholipids to the site of damage.
**Regulation:**
The activity of PLTPs is tightly regulated by a variety of factors, including:
* **Lipid concentration gradients:** PLTPs are more active when there is a difference in the concentration of specific phospholipids between the donor and acceptor membranes.
* **Protein-protein interactions:** PLTPs can interact with other proteins, such as membrane-associated proteins, to regulate their activity and target specificity.
* **Cellular signaling pathways:** PLTP activity can be modulated by cellular signaling pathways, ensuring that phospholipid transfer is coordinated with other cellular processes.
**Conclusion:**
Phospholipid transfer to membranes is a vital process that underpins a wide range of cellular functions. PLTPs, as key players in this process, play a crucial role in maintaining membrane integrity, regulating membrane composition, and facilitating signal transduction. Understanding the molecular mechanisms and regulation of phospholipid transfer is essential for unraveling the complexities of cellular organization and function.'
"
Protein | Definition | Taxonomy |
---|---|---|
P2X purinoceptor 7 | A P2X purinoceptor 7 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q99572] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
oxatomide | oxatomide : A member of the class of benzimidazoles that is 1,3-dihydro-2H-benzimidazol-2-one substituted by a 3-[4-(diphenylmethyl)piperazin-1-yl]propyl group at position 1. It is an anti-allergic drug. oxatomide: structure; an anti-allergic & an anti-asthmatic | benzimidazoles; diarylmethane; N-alkylpiperazine | anti-allergic agent; anti-inflammatory agent; geroprotector; H1-receptor antagonist; serotonergic antagonist |
pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid | 5'-phosphopyridoxal-6-azobenzene-2,4-disulfonic acid : An arenesulfonic acid that is pyridoxal 5'-phosphate carrying an additional 2,4-disulfophenylazo substituent at position 6. pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid: a novel antagonist that selectively blocks P2 purinoceptor receptors; a useful tool to study co-transmission in tissues when ATP and coexisting neurotransmitters act in concert | arenesulfonic acid; azobenzenes; methylpyridines; monohydroxypyridine; organic phosphate; pyridinecarbaldehyde | purinergic receptor P2X antagonist |
suramin | suramin : A member of the class of phenylureas that is urea in which each of the amino groups has been substituted by a 3-({2-methyl-5-[(4,6,8-trisulfo-1-naphthyl)carbamoyl]phenyl}carbamoyl)phenyl group. An activator of both the rabbit skeletal muscle RyR1 and sheep cardiac RyR2 isoform ryanodine receptor channels, it has been used for the treatment of human African trypanosomiasis for over 100 years. Suramin: A polyanionic compound with an unknown mechanism of action. It is used parenterally in the treatment of African trypanosomiasis and it has been used clinically with diethylcarbamazine to kill the adult Onchocerca. (From AMA Drug Evaluations Annual, 1992, p1643) It has also been shown to have potent antineoplastic properties. | naphthalenesulfonic acid; phenylureas; secondary carboxamide | angiogenesis inhibitor; antinematodal drug; antineoplastic agent; apoptosis inhibitor; EC 2.7.11.13 (protein kinase C) inhibitor; GABA antagonist; GABA-gated chloride channel antagonist; purinergic receptor P2 antagonist; ryanodine receptor agonist; trypanocidal drug |
alpha,beta-methyleneadenosine 5'-triphosphate | alpha,beta-methyleneadenosine 5'-triphosphate: do not confuse with beta,gamma-methylene ATP; RN given refers to parent cpd | nucleoside triphosphate analogue | |
sb 203580 | imidazoles; monofluorobenzenes; pyridines; sulfoxide | EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor; geroprotector; Hsp90 inhibitor; neuroprotective agent | |
8-azidoadenosine 5'-triphosphate | |||
6-thioinosine-5'-triphosphate | organic molecule | ||
mrs2159 | MRS2159: an antagonist of both P2X1 and P2X7 receptors | ||
imd 0354 | N-(3,5-bis(trifluoromethyl)phenyl)-5-chloro-2-hydroxybenzamide: a cardioprotective agent that inhibits IkappaB kinase beta (IKKbeta); structure in first source | benzamides | |
kn 62 | KN 62: inhibitor of Ca/calmodulin-dependent protein kinase II | piperazines | |
az 11645373 | AZ 11645373: InChIKey: VQEHBLGYANQWEA-UHFFFAOYSA-N | ||
az10606120 | AZ10606120: a P2X7 receptor antagonist | ||
ce 224,535 | CE 224,535: structure in first source | ||
a-438079 | |||
af 353 | 5-(5-iodo-2-isopropyl-4-methoxyphenoxy)pyrimidine-2,4-diamine: a P2X3 and P2X2/3 receptor antagonist; structure in first source | ||
gsk1482160 | |||
a-839977 | A-839977: a selective P2X7 receptor antagonist, analgesic; structure in first source | ||
jnj-47965567 | JNJ-47965567: a P2X7 purinergic receptor antagonist; structure in first source | ||
mk-8742 | elbasvir : A complex organic heterotetracyclic compound that is a hepatitis C virus nonstructural protein 5A inhibitor used in combination with grazoprevir (under the brand name Zepatier) for treatment of chronic HCV genotypes 1 or 4 infection in adults. elbasvir: inhibits NS5A protein of hepatitis C virus | carbamate ester; imidazoles; L-valine derivative; N-acylpyrrolidine; organic heterotetracyclic compound; ring assembly | antiviral drug; hepatitis C virus nonstructural protein 5A inhibitor; hepatoprotective agent |